Company research / KYMR
Kymera Therapeutics, Inc. (KYMR)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2025-12-31, Kymera Therapeutics, Inc. reported revenue of $39.21M. Revenue fell 16.7% from the prior annual period.
Key ratios (year ended 2025-12-31)
-891.1%
Operating margin
-794.0%
Net margin
-19.7%
Return on year-end equity
-16.7%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.